2Jnicz R, Nowalany - Kozielska E, Wojciechowska C, et al. Randomized, placebo - controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopahty: two - year follow - up results [ J].Circulation, 2001, 104: 39-45.
3Laufs U, Wassmann S, Schackmann S, et al. Bebeficial effects of statins in patients with non - ischemic heart failure [ J ]. Kardiol, 2004.93:103 -108.
4Mobini R, Maschke H, Waagstein F. New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapy [ J ]. Autoimmunity Reviews, 2004, 3: 277-284.
5Nash I. Implantable cardioverter- 07. defibrillators [ J ]. N Eng J Med, 2005, 325:2022-2025.
7Cleland JGF, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure [ J ]. Engl J Med, 2005, 325: 1539- 1549.
8Bax JJ, Abraham T, Barold SS, et al. Cardiac resynchronization therapy: Part 1 - issues before device impanlation [ J]. J Am Coll Cardiol, 2005, 46:2153 -2167.
